Atlas Trials

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

Clinical trial NCT04605952 · COMPLETED

Trial details

NCT number
NCT04605952
Sponsor
Tata Main Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19
Start date
2020-07-01
Primary completion
2020-08-30
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.